Estrogen activity as a preventive and therapeutic target in thyroid cancer

Shilpi Rajoria, Robert Suriano, Andrea L. George, Arul Kumaran Shanmugam, Casey Jussim, Edward J. Shin, Augustine L. Moscatello, Jan Geliebter, Angelo Carpi, Raj K. Tiwari

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Thyroid cancer is the most common endocrine-related cancer with increasing incidences during the last five years. Interestingly, according to the American Thyroid Association, the incidences of thyroid proliferative diseases occur four to five times more in women than in men with the risk of developing thyroid disorders being one in every eight females. Several epidemiological studies have suggested a possible correlation between incidences of thyroid malignancies and hormones but the precise contribution of estrogen in thyroid proliferative disease initiation, and progression is not well understood. This review is an attempt to define the phenotypic and genotypic modulatory effects of estrogen on thyroid proliferative diseases. The significance and relevance of expression of estrogen receptors, α and β, in normal and malignant thyroid tissues and their effects on different molecular pathways involved in growth and function of the thyroid gland are discussed. These novel findings open up areas of developing alternative therapeutic treatments and preventive approaches which employ the use of antiestrogen to treat thyroid malignancies.

Original languageEnglish (US)
Pages (from-to)151-158
Number of pages8
JournalBiomedicine and Pharmacotherapy
Volume66
Issue number2
DOIs
StatePublished - Mar 1 2012

Fingerprint

Thyroid Neoplasms
Thyroid Diseases
Thyroid Gland
Estrogens
Incidence
Endocrine Gland Neoplasms
Estrogen Receptor Modulators
Therapeutics
Thyroid Hormones
Estrogen Receptors
Disease Progression
Epidemiologic Studies
Neoplasms
Growth

Keywords

  • Antiestrogen
  • Estrogen
  • Estrogen receptor
  • Thyroid cancer
  • Thyroid proliferative diseases

ASJC Scopus subject areas

  • Pharmacology

Cite this

Rajoria, S., Suriano, R., George, A. L., Shanmugam, A. K., Jussim, C., Shin, E. J., ... Tiwari, R. K. (2012). Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine and Pharmacotherapy, 66(2), 151-158. https://doi.org/10.1016/j.biopha.2011.11.010

Estrogen activity as a preventive and therapeutic target in thyroid cancer. / Rajoria, Shilpi; Suriano, Robert; George, Andrea L.; Shanmugam, Arul Kumaran; Jussim, Casey; Shin, Edward J.; Moscatello, Augustine L.; Geliebter, Jan; Carpi, Angelo; Tiwari, Raj K.

In: Biomedicine and Pharmacotherapy, Vol. 66, No. 2, 01.03.2012, p. 151-158.

Research output: Contribution to journalReview article

Rajoria, S, Suriano, R, George, AL, Shanmugam, AK, Jussim, C, Shin, EJ, Moscatello, AL, Geliebter, J, Carpi, A & Tiwari, RK 2012, 'Estrogen activity as a preventive and therapeutic target in thyroid cancer', Biomedicine and Pharmacotherapy, vol. 66, no. 2, pp. 151-158. https://doi.org/10.1016/j.biopha.2011.11.010
Rajoria S, Suriano R, George AL, Shanmugam AK, Jussim C, Shin EJ et al. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine and Pharmacotherapy. 2012 Mar 1;66(2):151-158. https://doi.org/10.1016/j.biopha.2011.11.010
Rajoria, Shilpi ; Suriano, Robert ; George, Andrea L. ; Shanmugam, Arul Kumaran ; Jussim, Casey ; Shin, Edward J. ; Moscatello, Augustine L. ; Geliebter, Jan ; Carpi, Angelo ; Tiwari, Raj K. / Estrogen activity as a preventive and therapeutic target in thyroid cancer. In: Biomedicine and Pharmacotherapy. 2012 ; Vol. 66, No. 2. pp. 151-158.
@article{045536a1a16d46baae82ed2c3fc8df26,
title = "Estrogen activity as a preventive and therapeutic target in thyroid cancer",
abstract = "Thyroid cancer is the most common endocrine-related cancer with increasing incidences during the last five years. Interestingly, according to the American Thyroid Association, the incidences of thyroid proliferative diseases occur four to five times more in women than in men with the risk of developing thyroid disorders being one in every eight females. Several epidemiological studies have suggested a possible correlation between incidences of thyroid malignancies and hormones but the precise contribution of estrogen in thyroid proliferative disease initiation, and progression is not well understood. This review is an attempt to define the phenotypic and genotypic modulatory effects of estrogen on thyroid proliferative diseases. The significance and relevance of expression of estrogen receptors, α and β, in normal and malignant thyroid tissues and their effects on different molecular pathways involved in growth and function of the thyroid gland are discussed. These novel findings open up areas of developing alternative therapeutic treatments and preventive approaches which employ the use of antiestrogen to treat thyroid malignancies.",
keywords = "Antiestrogen, Estrogen, Estrogen receptor, Thyroid cancer, Thyroid proliferative diseases",
author = "Shilpi Rajoria and Robert Suriano and George, {Andrea L.} and Shanmugam, {Arul Kumaran} and Casey Jussim and Shin, {Edward J.} and Moscatello, {Augustine L.} and Jan Geliebter and Angelo Carpi and Tiwari, {Raj K.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1016/j.biopha.2011.11.010",
language = "English (US)",
volume = "66",
pages = "151--158",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "2",

}

TY - JOUR

T1 - Estrogen activity as a preventive and therapeutic target in thyroid cancer

AU - Rajoria, Shilpi

AU - Suriano, Robert

AU - George, Andrea L.

AU - Shanmugam, Arul Kumaran

AU - Jussim, Casey

AU - Shin, Edward J.

AU - Moscatello, Augustine L.

AU - Geliebter, Jan

AU - Carpi, Angelo

AU - Tiwari, Raj K.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Thyroid cancer is the most common endocrine-related cancer with increasing incidences during the last five years. Interestingly, according to the American Thyroid Association, the incidences of thyroid proliferative diseases occur four to five times more in women than in men with the risk of developing thyroid disorders being one in every eight females. Several epidemiological studies have suggested a possible correlation between incidences of thyroid malignancies and hormones but the precise contribution of estrogen in thyroid proliferative disease initiation, and progression is not well understood. This review is an attempt to define the phenotypic and genotypic modulatory effects of estrogen on thyroid proliferative diseases. The significance and relevance of expression of estrogen receptors, α and β, in normal and malignant thyroid tissues and their effects on different molecular pathways involved in growth and function of the thyroid gland are discussed. These novel findings open up areas of developing alternative therapeutic treatments and preventive approaches which employ the use of antiestrogen to treat thyroid malignancies.

AB - Thyroid cancer is the most common endocrine-related cancer with increasing incidences during the last five years. Interestingly, according to the American Thyroid Association, the incidences of thyroid proliferative diseases occur four to five times more in women than in men with the risk of developing thyroid disorders being one in every eight females. Several epidemiological studies have suggested a possible correlation between incidences of thyroid malignancies and hormones but the precise contribution of estrogen in thyroid proliferative disease initiation, and progression is not well understood. This review is an attempt to define the phenotypic and genotypic modulatory effects of estrogen on thyroid proliferative diseases. The significance and relevance of expression of estrogen receptors, α and β, in normal and malignant thyroid tissues and their effects on different molecular pathways involved in growth and function of the thyroid gland are discussed. These novel findings open up areas of developing alternative therapeutic treatments and preventive approaches which employ the use of antiestrogen to treat thyroid malignancies.

KW - Antiestrogen

KW - Estrogen

KW - Estrogen receptor

KW - Thyroid cancer

KW - Thyroid proliferative diseases

UR - http://www.scopus.com/inward/record.url?scp=84858287895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858287895&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2011.11.010

DO - 10.1016/j.biopha.2011.11.010

M3 - Review article

VL - 66

SP - 151

EP - 158

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 2

ER -